Tuesday, August 11, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
MarketSouth Korea's Big Three Post ₩225.9B Q2 RevenuetodayMarketDaewoong's NABOTA Enters Seventh Middle East Market2 days agoRegulatoryBotox Masseter Indication Moves Closer to FDA OKtodayRegulatoryFDA Accepts BOTOX Masseter sBLA—Jawline Approval Path Clear2 days agoBusiness & M&AIndonesia Opens First Botulinum Toxin PlanttodayDevices & TechInMode Q2 Beats EPS Forecast, Revenue Tops Estimates2 days agoBusiness & M&AGalderma Raises 2026 Guidance After Robust H1todayBusiness & M&AEvolus Q2 Revenue Hits $84.1M, Raises 2026 Guidance2 days agoBusiness & M&AEvolus Posts Third Straight Profitable QuarteryesterdayRegulatoryFDA Accepts BOTOX Cosmetic sBLA for Masseter ProminenceyesterdayBusiness & M&AEvolus Q2 Revenue Surges 21%, Adjusted EBITDA Swings PositiveyesterdayBusiness & M&APerceptive Advisors Takes New Stake in Evolusyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Injectables

RHA Dynamic Volume Cleared for Midface Augmentation — Revance Expands Dynamic Filler Footprint

Revance's dynamic HA platform gains a new indication for age-related volume loss, positioning RHA as a competitor in the structural filler space.

Image: Inside MedSpa

Revance's RHA Dynamic Volume received FDA clearance for midface augmentation and age-related volume loss, expanding the RHA product line beyond its original dynamic-expression focus. RHA fillers are engineered to move with facial expression (lower G-prime, higher elasticity) and are positioned as a bridge between traditional HA fillers and biostimulators in the volumization hierarchy.

The midface indication is clinically significant: it's a high-visibility zone where volume loss drives patient demand, and the dynamic properties of RHA may offer advantages over static HA fillers in maintaining natural movement. This directly competes with Juvéderm Voluma, Restylane Lyft, and off-label use of biostimulators like Radiesse and Sculptra.

Dynamic HA filler now cleared for midface volume—a new competitor in the structural augmentation space.

For practices, RHA Dynamic Volume represents an alternative volumization pathway—particularly valuable if you're already using RHA for expression lines and want to consolidate supplier relationships. Revance's rebate and loyalty programs (Revance Rewards) will be key to driving adoption. The indication also signals the market's continued segmentation by clinical use case rather than product category.

Source: original report ↗

Frequently asked questions

What is RHA Dynamic Volume and what is it FDA cleared for?

RHA Dynamic Volume is Revance's newest HA filler engineered to move with facial expressions (lower G-prime, higher elasticity). It's FDA cleared for midface augmentation and age-related volume loss, positioning it as a dynamic alternative to static fillers like Juvéderm Voluma and Restylane Lyft.

How does RHA Dynamic Volume differ from traditional HA fillers?

RHA fillers have lower G-prime and higher elasticity, allowing them to move naturally with facial expressions rather than remaining static. This dynamic property may better preserve natural facial movement in high-mobility zones like the midface compared to traditional HA fillers.

Is RHA Dynamic Volume a competitor to biostimulators like Sculptra and Radiesse?

RHA Dynamic Volume is positioned as a bridge between traditional HA fillers and biostimulators in the volumization hierarchy. While it competes with off-label biostimulator use for midface volume, it offers immediate results unlike biostimulators, which require time for collagen stimulation.

What are the business advantages of adding RHA Dynamic Volume to a practice?

If you're already using RHA for expression lines, RHA Dynamic Volume lets you consolidate your filler supplier relationship and cross-sell within the same product family. Revance's Revance Rewards rebate and loyalty programs also incentivize adoption.

What is the midface and why is it clinically significant for fillers?

The midface includes the cheeks and under-eye area—a high-visibility zone where age-related volume loss is a major driver of patient demand. Dynamic fillers like RHA may offer advantages here because the midface moves significantly during facial expressions.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/rha-dynamic-volume-midface-fda-clearance/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo